{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:15:16Z","timestamp":1792602916039,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.ejmech.2021.113682","type":"journal-article","created":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T02:20:33Z","timestamp":1625278833000},"page":"113682","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Synthesis and computational studies of novel fused pyrimidinones as a promising scaffold with analgesic, anti-inflammatory and COX inhibitory potential"],"prefix":"10.1016","volume":"224","author":[{"given":"Mona F.","family":"Said","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan H.","family":"Georgey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman R.","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2021.113682_bib1","doi-asserted-by":"crossref","first-page":"553","DOI":"10.4155\/fmc-2016-0240","article-title":"Synthesis and molecular docking of new imidazoquinazolinones as analgesic agents and selective COX-2 inhibitors","volume":"9","author":"Hassanein","year":"2017","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113682_bib2","doi-asserted-by":"crossref","first-page":"112066","DOI":"10.1016\/j.ejmech.2020.112066","article-title":"Design, synthesis and biological evaluation of novel pyrazole sulfonamide derivatives as dual COX-2\/5-LOX inhibitors","volume":"189","author":"Gedawy","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113682_bib3","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.ejmech.2013.03.005","article-title":"Synthesis of novel 1,3,4-trisubstituted pyrazoles as anti-inflammatory and analgesic agents","volume":"63","author":"Ragab","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113682_bib4","series-title":"Foye's Principles of Medicinal Chemistry","article-title":"Nonsteroidal anti-inflammatory drugs","author":"Borne","year":"2008"},{"key":"10.1016\/j.ejmech.2021.113682_bib5","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1248\/cpb.c13-00314","article-title":"Pyrazolone derivatives: synthesis, anti-inflammatory, analgesic, quantitative structure\u2013activity relationship and in\u00a0vitro studies","volume":"61","author":"Ragab","year":"2013","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2021.113682_bib6","series-title":"Wilson and Gisvold's Textbook of Organic Medicinal and Pharmaceutical Chemistry","article-title":"Analgesics","author":"Friel","year":"2011"},{"key":"10.1016\/j.ejmech.2021.113682_bib7","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/S0006-2952(01)00747-X","article-title":"Dual inhibitors of cyclooxygenase and 5-lipoxygenase. A new avenue in anti-inflammatory therapy?","volume":"62","author":"Fiorucci","year":"2001","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113682_bib8","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1016\/S0002-9343(97)00203-9","article-title":"Mechanism of action of nonsteroidal antiinflammatory drugs","volume":"104","author":"Vane","year":"1998","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ejmech.2021.113682_bib9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.bcp.2006.07.037","article-title":"Prostanoids in nociception and pain","volume":"73","author":"Zeilhofer","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113682_bib10","first-page":"26","article-title":"Choosing nonselective NSAIDs and selective COX-2 inhibitors in the elderly. A clinical use pathway","volume":"62","author":"Stillman","year":"2007","journal-title":"Geriatrics"},{"key":"10.1016\/j.ejmech.2021.113682_bib11","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1161\/01.ATV.0000219672.68024.bc","article-title":"COX-2 in cardiovascular disease","volume":"26","author":"Bishop-Bailey","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejmech.2021.113682_bib12","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/1-4020-5688-5_8","article-title":"A\u00a0biological rationale for the cardiotoxic effects of rofecoxib: comparative analysis with other COX-2 selective agents and NSAIDs","volume":"42","author":"Mason","year":"2007","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.ejmech.2021.113682_bib13","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.2174\/0929867003374255","article-title":"COX-2 selectivity and inflammatory processes","volume":"7","author":"Ryn","year":"2000","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113682_bib14","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.2174\/0929867003374237","article-title":"Structural approaches to explain the selectivity of COX-2 inhibitors: is there a common pharmacophore ?","volume":"7","author":"Dannhardt","year":"2000","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113682_bib15","first-page":"9","article-title":"Synthesis and analgesic activity of novel pyrimidine derivatives of coumarin moiety","volume":"19","author":"Gupta","year":"2010","journal-title":"Analele Universit\u0103\u0143ii din Bucuresti"},{"key":"10.1016\/j.ejmech.2021.113682_bib16","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2478\/v10007-008-0024-1","article-title":"Synthesis and evaluation of analgesic, anti-inflammatory and ulcerogenic activities of some triazolo- and 2-pyrazolyl-pyrido[2,3-d]-pyrimidines","volume":"58","author":"Hafez","year":"2008","journal-title":"Acta Pharm."},{"key":"10.1016\/j.ejmech.2021.113682_bib17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0223-5234(02)00009-0","article-title":"Design and synthesis of some substituted 1H-pyrazolyl-thiazolo[4,5-d]pyrimidines as anti-inflammatory-antimicrobial Agents","volume":"38","author":"Bekhit","year":"2003","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113682_bib18","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.bioorg.2019.01.031","article-title":"COX-1\/COX-2 inhibition assays and histopathological study of the new designed anti-inflammatory agent with a pyrazolopyrimidine core","volume":"86","author":"Abdelall","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2021.113682_bib19","doi-asserted-by":"crossref","first-page":"767","DOI":"10.3109\/14756366.2010.550890","article-title":"Synthesis and biological evaluation of 2,5-disubstituted1,3,4-oxadiazole derivatives with both COX and LOX inhibitory activity","volume":"26","author":"Akhter","year":"2011","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113682_bib20","doi-asserted-by":"crossref","first-page":"658","DOI":"10.3109\/14756366.2011.606543","article-title":"Syntheses and evaluation of anti-inflammatory, analgesic and ulcerogenic activities of 1,3,4-oxadiazole and 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazole derivatives","volume":"27","author":"Chawla","year":"2012","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113682_bib21","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1007\/s00044-012-0298-1","article-title":"Synthesis of new oxadiazole derivatives as anti-inflammatory, analgesic, and antimicrobial agents","volume":"22","author":"Ramaprasad","year":"2013","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2021.113682_bib22","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1039\/C6MD00367B","article-title":"Synthesis of novel thiadiazole derivatives as selective COX-2 inhibitors","volume":"7","author":"Ragab","year":"2016","journal-title":"Med. Chem. Commun"},{"key":"10.1016\/j.ejmech.2021.113682_bib23","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/j.ejmech.2007.06.023","article-title":"Synthesis and anti-inflammatory evaluation of methylene bridged benzofuranyl imidazo[2,1-b][1,3,4]thiadiazoles","volume":"43","author":"Jadhav","year":"2008","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113682_bib24","doi-asserted-by":"crossref","first-page":"81","DOI":"10.33945\/SAMI\/PCBR.2020.2.1","article-title":"A\u00a0review on analgesic and anti-inflammatory activities of various piperazinyl containing pyridazine derivatives","volume":"3","author":"Alam","year":"2020","journal-title":"Prog. Chem. Biochem. Res."},{"key":"10.1016\/j.ejmech.2021.113682_bib25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejmech.2021.113682_bib26","doi-asserted-by":"crossref","first-page":"5735","DOI":"10.1016\/j.bmcl.2011.08.022","article-title":"2,5-Disubstituted-1,3,4-oxadiazoles\/thiadiazole as surface recognition moiety: design and synthesis of novel hydroxamic acid based histone deacetylase inhibitors","volume":"21","author":"Rajak","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113682_bib27","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2323\/jgam.51.133","article-title":"Synthesis of Schiff bases of 2-amino-5-aryl-1,3,4-oxadiazoles and their evaluation for antimicrobial activities","volume":"51","author":"Mishra","year":"2005","journal-title":"J.\u00a0Gen. Appl. Microbiol."},{"key":"10.1016\/j.ejmech.2021.113682_bib28","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ejmech.2007.02.004","article-title":"Synthesis and CNS depressant activity of some novel 3-[5-substituted 1,3,4-thiadiazole-2-yl]-2-styryl quinazoline-4(3H)-ones","volume":"43","author":"Jatav","year":"2008","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113682_bib29","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0022-3565(25)26463-1","article-title":"The effect of aggregation, electric shock and adrenergic bloking drugs on inhibition of the \"writhing syndrome","volume":"139","author":"Okun","year":"1963","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2021.113682_bib30","series-title":"Statistical Methods in Biological Assay","first-page":"597","author":"Finney","year":"1964"},{"key":"10.1016\/j.ejmech.2021.113682_bib31","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3181\/00379727-111-27849","article-title":"Carrageenan-induced edema in hind paw of the rat as an assay for anti-inflammatory drugs","volume":"111","author":"Winter","year":"1962","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.ejmech.2021.113682_bib32","first-page":"217","article-title":"Effect of encapsulation of flufenamic acid with acrylic resins on its bioavailability and gastric ulcerogenic activity in rats","volume":"29","author":"Meshali","year":"1983","journal-title":"Acta Pharm. Technol."},{"key":"10.1016\/j.ejmech.2021.113682_bib33","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0016-5085(19)34024-7","article-title":"Effect of prostaglandin E1 on gastric secretion and ulcer formation in the rat","volume":"55","author":"Robert","year":"1968","journal-title":"Gastroenterology"},{"issue":"72","key":"10.1016\/j.ejmech.2021.113682_bib34","first-page":"77","volume":"52","author":"Katritzky","year":"2005","journal-title":"CODESSA-Pro software manual"},{"key":"10.1016\/j.ejmech.2021.113682_bib35","doi-asserted-by":"crossref","first-page":"28534","DOI":"10.1039\/C9RA04321G","article-title":"Facile synthetic approach towards vasorelaxant active 4-hydroxyquinazoline-4-carboxamides","volume":"9","author":"Aziz","year":"2019","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2021.113682_bib36","doi-asserted-by":"crossref","first-page":"6619","DOI":"10.1039\/C5OB00410A","article-title":"Rational design, synthesis and molecular modeling studies of novel anti-oncological alkaloids against melanoma","volume":"13","author":"Girgis","year":"2015","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2021.113682_bib37","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.4155\/fmc-2020-0109","article-title":"Synthesis of new ibuprofen hybrid conjugates as potential anti-inflammatory and analgesic agents","volume":"12","author":"Panda","year":"2020","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113682_bib38","doi-asserted-by":"crossref","first-page":"33761","DOI":"10.1039\/C9RA05661K","article-title":"Synthesis, human topoisomerase II\u03b1 inhibitory properties and molecular modeling studies of anti-proliferative curcumin mimics","volume":"9","author":"Fawzy","year":"2019","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2021.113682_bib39","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/384644a0","article-title":"Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents","volume":"384","author":"Kurumbail","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2021.113682_bib40","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1016\/j.bmcl.2015.04.023","article-title":"Synthesis and QSAR study of novel anti-inflammatory active mesalazine-metronidazole conjugates","volume":"25","author":"Naumov","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421005316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421005316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:28:24Z","timestamp":1759328904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421005316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":40,"alternative-id":["S0223523421005316"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113682","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and computational studies of novel fused pyrimidinones as a promising scaffold with analgesic, anti-inflammatory and COX inhibitory potential","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113682","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113682"}}